Gene expression profile and genomic changes in disease progression of early-stage chronic lymphocytic leukemia
- 1 January 2008
- journal article
- research article
- Published by Ferrata Storti Foundation (Haematologica) in Haematologica
- Vol. 93 (1) , 132-136
Abstract
The biologic mechanisms involved in the clinical progression from early stages of patients with chronic lymphocytic leukemia (CLL) are not well known. We investigated sequential samples from 16 untreated CLL patients obtained at diagnosis in early stage and after progression before treatment. One patient had a p16 INK4a homozygous deletion at diagnosis and progression, and 3 patients acquired a p53 mutation, gains of 5q21-q23 and 11pter-p14, and a gain of chromosome 12 respectively, during the progression of the disease. Gene expression profile analysis showed a significant modulation of 58 genes with a particular downregulation of genes that are inhibitors of cell adhesion and motility.Keywords
This publication has 7 references indexed in Scilit:
- ZAP-70 expression is associated with enhanced ability to respond to migratory and survival signals in B-cell chronic lymphocytic leukemia (B-CLL)Blood, 2006
- Additional Genetic High-Risk Features Such As 11q Deletion, 17p Deletion, and V3-21 Usage Characterize Discordance of ZAP-70 and VH Mutation Status in Chronic Lymphocytic LeukemiaJournal of Clinical Oncology, 2006
- Perspectives on the use of new diagnostic tools in the treatment of chronic lymphocytic leukemiaBlood, 2005
- Identification of progression markers in B-CLL by gene expression profilingExperimental Hematology, 2005
- Grb7 expression and cellular migration in chronic lymphocytic leukemia: a comparative study of early and advanced stage diseaseLeukemia, 2004
- Genetics of chronic lymphocytic leukemia: genomic aberrations and VH gene mutation status in pathogenesis and clinical courseLeukemia, 2002
- Multiple cell cycle regulator alterations in Richter's transformation of chronic lymphocytic leukemiaLeukemia, 2002